Kelleher Financial Advisors’s Blueprint Medicines BPMC Stock Holding History

Kelleher Financial Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-300	Closed	-$38.5K	–	867
2026 Q1	$38.5K	Buy	+300	New	+$38.5K	0.01%	410

Other funds holding BPMC

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Kelleher Financial Advisors's BPMC Position: Q2 2026 in Review

Kelleher Financial Advisors sold out of Blueprint Medicines (BPMC) in Q2 2026, closing a stake of 300 shares — an estimated $38.5K sold.

Kelleher Financial Advisors first reported a position in BPMC in Q1 2026 and held it in 1 quarter. The position peaked at $38.5K in Q1 2026. 1 fund tracked by Wall St. Rank holds BPMC as of Q2 2026.

Kelleher Financial Advisors reported no remaining Blueprint Medicines position as of Q2 2026 after selling out during the quarter.
Kelleher Financial Advisors sold 300 Blueprint Medicines shares in Q2 2026, an estimated $38.5K.
Kelleher Financial Advisors first reported a position in Blueprint Medicines in Q1 2026 and held it in 1 quarter.
Kelleher Financial Advisors's Blueprint Medicines position peaked at $38.5K in Q1 2026.
1 fund tracked by Wall St. Rank held Blueprint Medicines as of Q2 2026.

Based on Kelleher Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.